- 4 سال پیش
- 266
- 02:55
Rivaroxaban vs Apixaban in major ischemic or hemorrhagic events in AF
Daily Cardiology
0
Avatar
کاربر شنوتواولین نفر کامنت بزار
- 262
- 4 سال پیش
A review on recent antiplatelet therapy trials...
A review on recent antiplatelet therapy trials
11:57
- 262
- 4 سال پیش
11:57
- 279
- 4 سال پیش
2021 post-ESC headlines...
2021 post-ESC headlines
01:33:40
- 279
- 4 سال پیش
01:33:40
The seventh episode of Cardio-Watch: ESC 2021...
The seventh episode of Cardio-Watch: ESC 2021
09:21
- 248
- 4 سال پیش
09:21
Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19
- 254
- 4 سال پیش
The role of Heparin in the management of thrombosis in COVID-19...
The role of Heparin in the management of thrombosi...
03:44
- 254
- 4 سال پیش
03:44
The sixth episode of Cardio-Watch: Electrophysiology...
The sixth episode of Cardio-Watch: Electrophysiolo...
08:24
- 274
- 4 سال پیش
08:24
- 255
- 4 سال پیش
Neprilysin Inhibitors to prevent LV remodeling post MI...
Neprilysin Inhibitors to prevent LV remodeling pos...
03:35
- 255
- 4 سال پیش
03:35
Midodrine in vasovagal syndrome prevention...
Midodrine in vasovagal syndrome prevention
01:57
- 294
- 4 سال پیش
01:57
Impact of Dapagliflozin on the survival of HFrEF patients...
Impact of Dapagliflozin on the survival of HFrEF p...
02:26
- 263
- 4 سال پیش
02:26
Milrinone vs. Dobutamine: DOREMI trial...
Milrinone vs. Dobutamine: DOREMI trial
01:39
- 302
- 4 سال پیش
01:39
تمامی حقوق این وبسایت متعلق به شنوتو است